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Objective. To search brain perfusion MRI (pMRI) changes in Behcet’s disease (BD) with or without neurological involvement.
MaterialsandMethod.ThepMRIwereperformedin34patientswithBDand16healthycontrols.Basedonneurologicexamination
and post-contrast MRI, 12 patients were classiﬁed as Neuro-Behcet (group 1, NBD) and 22 patients as BD without neurological
involvement(group2).Meantransittime(MTT),timetopeak(TTP),relativecerebralbloodvolume(rCBV),andrelativecerebral
blood ﬂow (rCBF) were obtained and compared to those of healthy control group (group 3). Results. There was a signiﬁcant
diﬀerence in the MTT and rCBF within the pons and parietal cortex in groups 1 and 2. rCBV increased in cerebral pedicle in group
1 compared with groups 2 and 3. In the temporal lobe white matter, prolonged MTT and decreased rCBF were found in groups 1
and 2. In the corpus striatum, internal capsule, and periventricular white matter, rCBF increased in group 1 compared with group
3 and decreased in groups 1 and 2. Conclusion. Brain pMRI is a very sensitive method to detect brain involvement in patients with
BD and aids the clinical diagnosis of NBD, especially in patients with negative MRI ﬁndings.
1.Introduction
Behcet’s disease (BD) was ﬁrst recognized as a clinical entity
by the Turkish dermatologist Hulusi Behcet. It is a multi-
systemic, recurrent, inﬂammatory disorder and aﬀects the
central nervous system (CNS) [1]. Clinical manifestations
related to CNS involvement are extremely variable and are
not always easily recognized [2].
Brain involvement may be caused by either primary
parenchymal lesions or vascular damage. Signs or symptoms
attributabletoCNSinvolvementhavebeenreportedin10%–
50% of BD [3, 4]. MRI ﬁndings of Neuro-Behcet’s disease
(NBD) are nonspeciﬁc. Small irregular hyperintensities can
be observed on the FLAIR and T2-weighted images. The
most commonly aﬀected region is the mesodiencephal-
ic junction, followed by the pontobulbar region [5, 6].
Hypothalamic region, basal ganglia, cerebral hemispheres,
cerebellum, and spinal cord were rarely involved [5]. The
exact pathogenesis of the disease is still unknown; how-
ever; that is triggered by exogenous factors, with genetic
components that predispose to the autoimmune vasculitis
has been suggested [7]. Behcet’s disease can cause immune-
mediated vasculitis aﬀecting small and large sized ves-
sels. The parenchymal distribution of lesions, especially in
mesodiencephalic junction, supports small vessel vasculitis
involving mainly venules [8, 9]. Perivascular inﬂammation
might be important to understanding the pathogenesis of
NBD [10]. Intermittent acute perivascular inﬂammation
might contribute to the destruction of CNS parenchyma
leading to loss of neuronal functions [10].
Diﬀerent advanced MRI techniques, including Magnetic
Resonance Spectroscopy (MRS) and Diﬀusion Weighted
Imaging (DWI), capable of detecting subtle ultrastructural
changes are now employed to depict the parenchyma
involvement [11–16]. But so far, brain perfusion MRI
(pMRI) ﬁndings in patients with BD have not been reported.2 The Scientiﬁc World Journal
pMRIenablesassessmentofregionalcerebralhemodynamics
using a variety of methods [17]. pMRI provides a relative
and/or absolute measurement of the parameters of cerebral
microvascularisation: regional blood volume, mean transit
time, regional blood ﬂow. The main applications of the
ﬁrst pass pMRI are vascular pathologies (vasculitis, ischemic
strokes, vasospasm) and tumoral pathologies. Our aim
was to investigate whether brain perfusion impairment in
patients with BD with or without neurological involvement
b ym e a n so fp M R Io c c u r s.
2.MaterialsandMethods
34 patients (14 female, 20 male, mean age 42.67 ± 10.74)
with BD diagnosed in the Department of Dermatology were
included into this study. First, neurological examinations
of patients were performed. According to the results of
neurological examination and conventional MRI ﬁndings,
patients were classiﬁed as NBD (group 1:12 patients)
and BD (group 2:22 patients). 16 healthy volunteers were
included as control group (group 3). The study protocol was
approved by the institutional ethical committee. All subjects
werefullyinformedandgavetheirwritteninformedconsent.
We routinely performed conventional MRI and pMRI
as part of the diagnostic assessment of all patients with
suspectedneurologicalinvolvementbyBD.1.5TMRIsystem
(Gyroscan Intera Master, Philips) was used for this study
using a standard head coil. The routine conventional MRI
sequences were used to identify anatomical structures and
conﬁrmtheabsenceofanystructuralorsignalabnormalities.
We obtained axial T1- and T2-weighted, coronal ﬂuid-
attenuated inversion recovery (FLAIR), and sagittal T1
weighted images. Contrast-enhanced axial and coronal T1-
weighted images were obtained after perfusion MRI.
For pMRI, gradient echo (FFE) sequence (TE: 30, TR:
500)withdynamicperfusionexaminationwasperformed.16
sections and 50 dynamic examinations wereperformed(slice
thickness: 7mm). 0.2mmol/kg contrast agent (gadolinium)
was given using a 18G IV catheter with automatic injection
pump. Slices were obtained with a 7sec delay. Perfusion
values were determined by using software. ROIs (regions of
interest) were placed into the most commonly aﬀected areas
reported in the literature. Average ROI sizes were arranged as
follows: pons (70–100mm2), cerebral pedicle (30–50mm2),
temporal lobe white matter (100–120mm2), thalamus (80–
120mm2), the corpus striatum (200–250mm2), internal
capsule posterior limb (30–50mm2), periventricular white
matter (140–170mm2), parietal cortex (30–50mm2), and
cerebellar white matter (130–160mm2). Perfusion maps and
rCBV (relative cerebral blood volume), MTT (mean transit
time), rCBF (relative cerebral blood ﬂow), and TTP (time to
peak) values were obtained and compared with the control
group and between groups.
3.StatisticalAnalysis
SPSS 13.0 (Statistical package for social scienses) program
was used for statistical analysis. Measurable variables, mean
(x) ± standard deviation (SD), and categorical data are
presented as number and percentage. Measurable variables
with the Shapiro Wilk normality test showed a normal
distribution (P>0.05). Comparing more than two groups
(group1,group2,andgroup3),one-wayanalysisofvariance
was used. The relationship between variables with Pearson’s
correlation analysis and evaluation of categorical data was
tested with Pearson Chi-square analysis. P<0.05 was
considered statistically signiﬁcant.
4. Results
MRI Findings:
12 patients were NBD (group 1). 22 patients (group 2)
had not had neurological involvement. Pons and cerebral
pedicle lesions were seen in 5 patients in MRI (Figure 1).
Seven patients had involvement of the periventricular and
subcortical white matter.
pMRI Findings:
(a) Patients with Behcet’s disease (totally, n = 34)
compared with the control group (n = 13) (Table 1):
(1) increased rCBV (p: 0,03) and prolonged MTT
(p: 0,04) in cerebral pedicle,
(2) increasedrCBV(p:0,00)andprolongedTTP(p:
0,03) in thalamus,
(3) increased rCBV (p: 0,01) and prolonged MTT
(p: 0,02) in temporal lobe white matter,
(4) prolonged MTT (p: 0,00) in corpus striatum,
(5) prolonged TTP (p: 0,03) in internal capsule
posterior limb
(6) increased rCBV (p:0 , 0 3 ) ,p r o l o n g e dT T P( p:
0,02) and MTT (p: 0,00) in periventricular
white matter,
(7) prolonged MTT (p: 0,01) and TTP (p: 0,02) in
cerebellar white matter.
(b) neuro-Behcet’s (NBD, group 1), BD (without neuro-
logic involvement; group 2), and the control group
(group 3) according to the localization of the average
perfusion values of the results of statistical compari-
son are presented in Figure 2 and Table 2.
Pons (Figure 2(a)):
(1) There was signiﬁcant diﬀerence in MTT values
between group 1-2 (p: 0,01), group 2-3 (p: 0,03), and
group 1–3 (p: 0,00). MTT values in patients with
Neuro-Behcet’s (group 1) was prolonged compared
t og r o u p2a n d3 .A l s o ,M T Tv a l u e si ng r o u p2w e r e
prolonged compared to control group.
(2) There was signiﬁcant diﬀerence rCBF values between
group 1–3 (p: 0,00) and group 2-3 (p: 0,00). rCBF
v a l u e si ng r o u p1a n d2c o m p a r e dt og r o u p3
decreased.The Scientiﬁc World Journal 3
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Figure 1: A female patient with neuro-Behcet’s disease. (a) T2-weighted fast spin-echo axial MR image shows patchy hyperintensities in
pons. (b) Contrast-enhanced T1-weighted echo axial MR image demonstrates nodular enhancement in pons. (c) ROIs (regions of interest)
were placed into pons and cerebellar white matter in perfusion MRI.
Cerebral Pedicle (Figure 2(b)):
(1) There was signiﬁcant diﬀerence in MTT values
between group 1-2 (p: 0,02) and group 1–3 (p: 0,00).
MTT values in group 1 were prolonged compared to
groups 2 and 3.
(2) There was signiﬁcant diﬀerence in rCBV values
between group 1-2 (p: 0,02) and group 1–3 (p: 0,03).
rCBV values in group 1 were prolonged.
Corpus Striatum (Figure 2(c)):
(1) MTT values in group 1 compared to groups 3 were
prolonged (p: 0,01).
(2) rCBF values between groups 1 and 3 (p: 0,05) and
groups2and3(p:0,02)showedsigniﬁcantdiﬀerence.
rCBF values of group 1 and 2 values were decreased.
Temporal Lobe White Matter (Figure 2(d)):
( 1 )M T Tv a l u e sb e t w e e ng r o u p s1a n d3( p: 0,01) and
groups2and3(p:0,01)showedsigniﬁcantdiﬀerence.
MTT values in group 1 and 2 were prolonged
compared with group 3.
(2) rCBF values in groups 1 and 2 compared with group
3( p: 0,00, and p: 0,01) showed signiﬁcant diﬀerence.
rCBF values in group 1 and 2 were decreased.4 The Scientiﬁc World Journal
Table 1: Perfusion parameter values of all Behcet’s patients and control group.
Locations
Total patients with Behcet’s disease (n = 34) Control group (n = 16)
rCBV
x ±SD
MTT
x ±SD
rCBF
x ±SD
TTP
x ±SD
rCBV
x ±SD
MTT
x ±SD
rCBF
x ±SD
TTP
x ±SD
Pons 2,54±1,24 12,64 ±5,83 0,21±0,09 41,23 ±8,08 2,40±0,76 7,71±1,99 0,33±0,14 39,41 ±5,55
Cerebral pedicle 3,24±2,20 12,08 ±6,52 0,27±0,14 40,60 ±7,89 2,77±1,12 8,64±3,24 0,35±0,15 39,88 ±5,36
Thalamus 2,86±1,66 13,77±14,04 0,26±0,13 41,09 ±7,75 2,40±0,84 7,10±1,67 0,36±0,17 38,26 ±4,80
Temporal lobe white
matter 7,28±5,46 18,52 ±9,70 0,38±0,15 42,64 ±8,54 5,52±2,32 10,71 ±
5,05 0,55±0,22 39,16 ±5,51
Corpus striatum 2,09±1,22 10,31 ±5,84 0,22±0,12 40,56±10,63 2,11±0,83 6,75±1,60 0,31±0,12 38,16 ±4,66
Internal capsule
posterior limb 2,50±1,76 14,32±10,08 0,18±0,08 40,32±10,54 2,01±0,91 7,90±5,45 0,30±0,11 37,93 ±5,06
Periventricular
white matter 1,93±1,51 13,15 ±7,13 0,14±0,07 41,72±10,02 1,71±0,74 8,16±3,03 0,20±0,06 40,06 ±5,04
Parietal cortex 2,77±1,22 12,15 ±5,36 0,25±0,10 40,48 ±8,56 2,76±1,09 7,80±3,18 0,37±0,14 39,52 ±5,12
Cerebellum 2,51±1,45 12,97 ±8,93 0,21±0,09 41,57±11,04 2,43±0,83 7,71±2,86 0,32±0,11 39,4 ±4,99
Table 2: Statistically signiﬁcant diﬀerences in perfusion parameters are presented.
Locations Group 1 (n:12) Group 2 (n:22) Group 3 (n:16)
Pons MTT 15,56 ±7,34α, 11,05 ±4,20α,β 7,71 ±1,99β,
rCBF 0,20 ±0,11 0,22 ±0,08β 0,33 ±0,14β,
Cerebral pedicle rCBV 4,26 ±2,82α, 2,68 ±1,58α 2,77 ±1,12
MTT 15,10 ±7,97α, 10,43 ±5,06α 8,64 ±3,24
Temporal lobe white matter MTT 19,54±10,90β, 17,97 ±9,20β 10,71 ±5,05β,
rCBF 0,35 ± 0,15 β, 0,39 ±0,15β 0,55 ±0,22β,
Corpus striatum MTT 11,73 ±4,16 9,53 ±6,54 6,75 ±1,60
rCBF 0,22 ±0,14 0,21 ±0,11β 0,31 ±0,12β,
Internal capsul posterior limb MTT 16,49±14,22 13,14 ±7,04 7,90 ±5,45
rCBF 0,19 ±0,09 0,18 ±0,07β 0,30 ±0,11β,
Periventricular white matter MTT 15,65 ±5,37 11,79 ±7,70 8,16 ±3,03
rCBF 0,15 ±0,09 0,13 ±0,05β 0,20 ±0,06β,
Parietal cortex MTT 13,56 ±6,73 11,38 ±4,43β 7,80 ±3,18β,
rCBF 0,24 ±0,07 0,26 ±0,11β 0,37 ±0,14β,
Cerebellum rCBF 0,18 ±0,09 0,23 ±0,09β 0,32 ±0,11β,
(a) Group 1 compared with group 2α
(b) Group 2 compared with group 3β
(c) Group 1 compared with group 3.
Internal Capsule Posterior Limb (Figure 2(e)):
(1) MTT values in group 1 also had a signiﬁcant increase
compared with group 3 (p: 0,01).
(2) rCBF values in group 1 and 2 compared with group 3
(p: 0,00, and p: 0,00) were decreased.
Periventricular White Matter (Figure 2(f)):
(1) MTT values in group 1 compared with group 3 were
signiﬁcantly prolonged (p: 0,00).
(2) rCBF values in groups 1 and 2 compared with group
3( p: 0,04, and p: 0,00) were decreased.
Parietal Cortex (Figure 2(g)):
(1) MTT values in group 1 compared with groups 2 and
3 were prolonged (p:0 , 0 0a n dp: 0,02).
(2) rCBF values in groups 1 and 2 compared with group
3( p: 0,00, p: 0,00) were decreased.
Cerebellar White Matter:
(1) rCBF values in group 1 and 2 compared with group 3
(p: 0,00, p: 0,00) were decreased.
5. Discussion
Behcet’s disease is characterized clinically by the presence
of a diagnostic triad of oral and genital aphthous ulcers,The Scientiﬁc World Journal 5
meningoencephalitis, and relapsing uveitis [1, 18]. The
disease is usually seen in the third decade and is more
common in men [19]. The disease prevalence is higher in
countries on the Silk Road [7]. Familial aggregation of the
disease has been reported mainly in Turkey and Japan.
Clinical and imaging data suggest that the clinical
variation is also seen with the neurological involvement. BD
is a systemic vasculitis of unknown origin with neurological
involvement. The etiological factors remain obscure, but
viral agents, immunological factors, genetic causes, bacterial
factors, and ﬁbrinolytic defects have been implicated [6, 20].
NBDisclassiﬁedintwomajorforms:(1)focalandmultifocal
parenchymal involvement associated with inﬂammatory dis-
easeofthesmallveins(80%),(2)betterprognosisandamore
limited with symptoms of cerebral venous sinus thrombosis
(20%).Oneisattributabletosmallvenousinﬂammatorydis-
ease with focal or multifocal CNS parenchymal involvement
and is seen in the majority of patients [5]. Several studies
reported neuropathologic ﬁndings in NBD. It causes inﬂam-
matory changes in the meninges and brain parenchyma with
perivascular lymphocytic inﬁltrates involving veins, venules,
capillaries, and, less frequently, arteries. As the lesions
become more chronic, gliosis, atrophy, and thickening and
ﬁbrosis of the meninges may ensue [4, 6, 7, 20].
Neuroimaging studies have shown that lesions are
generally located within the brainstem, occasionally with
extension to the diencephalon, or less commonly within
the periventricular and subcortical white matter. The most
commonly aﬀected region is the mesodiencephalic junction,
followed by the pontobulbar region [5, 6, 21]. Most patients
who do have mesodiencephalic junction lesions also show an
upward extension involving the diencephalic structures or a
downward extension involving the pontobulbar region [5, 6,
20].MRIiscurrentlythemostsensitiveandprevalenttoolfor
detecting CNS lesions. White matter lesions are usually mul-
tiple small foci of high intensity of T2-weighted images [21].
They are usually extensive, conﬂuent, and distributed over
the white matter without predilection for the periventricular
regions [21]. In our study, we showed hyperintense lesions
in pons and cerebral pedicles in 5 patients, in periventricular
and subcortical white matter in 7 patients on T2 and FLAIR
images. Hemispheric white matter lesions in patients with
NB are not common. Subcortical lesions are more frequent.
Subcortical lesions were found in 4 patients, and periventric-
ular white matter lesions were demonstrated in 3 patients.
pMRI is currently used to investigate the brain physi-
ology in healthy patients and in those with various brain
diseases. pMRI can demonstrate the altered physiologic state
of the cerebral vasculature immediately after an occlusive or
partially occlusive event. This physiologic state may be char-
acterized by parameters of tissue perfusion such as relative
cerebral blood volume (rCBV), relative cerebral blood ﬂow
(rCBF), and mean transit time (MTT) [22]. It can be used
in brain vascular diseases (vasculitis, angiopathy, ischemic
stroke), tumoral diseases (to evaluate neoangiogenesis and
tumoral vascularisation), and infectious or inﬂammatory
diseases (hypervascularisation).
pMRI seems to be very sensitive in disclosing brain
abnormalities in patients with BD and signs or symptoms of
CNSinvolvement,evenwithnegativeﬁndingsonbrainMRI.
NormalMRIﬁndingscannotexcludeapreviousneurological
attack in a patient with BD [23]. Akman-Demir et al. [23]
reported 22 patients with neurological involvement without
preceding neurological attacks in their study. Approximately
half of the patients were normal MRI ﬁndings. However,
the majority of the patients with normal MRI had silent
neurological involvement [23]. Although MRI ﬁndings are
normal, perfusion SPECT is sensitive about the results of
brain involvement in Behcet’s patients with neurological
symptoms. Vignole et al. [2] studied perfusion SPECT in 7
patients with BD. Hypoperfusion in right thalamus, caudate
nucleus,andleftfrontolateralregionwasdetectedinapatient
with headache. At the beginning of the left caudate nucleus
and left thalamus and in the temporal lobe in 3 patients
was found hypoperfusion. In our study, prolonged MTT
and decreased rCBF values were detected in corpus striatum
in patients with NB. pMRI ﬁndings obtained from the
corpus striatum in patients with NB indicate hypoperfusion.
Otherwise, decreased rCBF values in patients with Behcet’s
without neurological involvement also show hypoperfusion
and subclinic dysfunction in corpus striatum.
E i g h tp a t i e n t so fB Dw i t hn e u r o l o g i c a ls y m p t o m sw e r e
studied using perfusion SPECT, which disclosed areas of
hypoperfusion localized in the deep basal ganglia or in the
frontal and temporal cortex. MRI was normal in ﬁve of
them [24]. In another similar study performed in 10 adults
with neuropsychiatric manifestations related to BD [25],
whose MRI were normal, SPECT demonstrated hypoper-
fusion areas in the brains of all patients, with the parietal
and temporal lobes being the most commonly involved
regions. These perfusion SPECT ﬁndings, consistent with
multiple hypoperfusion areas that correlate with decreased
metabolic demand, are not speciﬁc for NBD, but they may
be interpreted as being indicative of early functional changes
in the brains in this patient population [25].
Vignole et al., in same study [2], detected hypoperfusion
in right mesiotemporal and laterotemporal cortex in a
patient. Prolonged MTT and decreased rCBF values were
found in temporal lobe white matter in patients with NB
and BD without neurological involvement in our study.
These ﬁndings conﬁrm hypoperfusion in temporal lobe in
white matter. MTT values obtained from parietal cortex in
patients with NB compared with Behcet’s and controls were
prolonged. rCBFvaluesin patients withNBD weredecreased
compared with controls. Garc´ ıa-Burillo et al. [26] studied
HMPAO brain perfusion SPECT in BD with neuropsychi-
atric symptoms. In patients without neurological symptoms
(without MRI ﬁndings), SPECT abnormalities incompatible
with the high proportion of primary indicate that blood
ﬂow deﬁcits or focal metabolic disorder that is probably
prematureindicatestheinvolvementofsubclinicalCNS[26].
In our study, in patients without neurological symptoms
were detected prolonged MTT and decreased rCBF values
in pons and temporal lobe white matter. In addition, rCBF
values of corpus striatum, internal capsule, PVWM, parietal
cortex, and cerebellum were decreased. Prolonged MTT and
decreased rCBF values without MRI involvement suggest
that subclinical dysfunction.6 The Scientiﬁc World Journal
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Figure 2: The comparative mean values of MTT and rCBF parameters between each of three groups in (a) pons (NBD: neuro-Behcet’s
disease (n:12)), (BD: Behcet’s disease (n:22)), (CG: control group (n:16)), (b) cerebral peduncle, (c) corpus striatum, (d) temporal lobe
white matter, (e) posterior limb of internal capsule, (f) periventricular white matter, (g) parietal cortex.
Kao et al. found hypoperfusion in gray matter in all
cases of 13 patients with NBD in SPECT study [27]. White
matter lesions in MRI were seen in only 4 cases. In our study,
MTT values obtained from parietal cortex in patients with
NBD were prolonged compared to group 2 and control. In
addition, rCBF values of patients with NBD and without
neurological symptoms were decreased. In patients with BD,
parietal cortex lesions on MRI were not detected. Decreased
rCBF values in gray matter suggesting that more easily deter-
mination of metabolic and functional changes in the brain.
6. Conclusion
Brain perfusion MRI is a very sensitive method to detect
brain involvement in patients with BD and may support
the clinical diagnosis of NBD, especially in patients with
negative MRI ﬁndings. We think pMRI has great potential
because it provides direct information related to regional
hypoperfusion caused by small vasculitic lesions. It may act
as complementary modality to increase the detection rate of
the aﬀected location in patients with NBD. pMRI results in
patients with BD with/or without neurological involvement
indicate hypoperfusion in diﬀerent regions of the brain.
Hypoperfusion ﬁndings in patients with NBD were much
more prominent. Detection of signs of hypoperfusion in
diﬀerent brain regions by pMRI in BD patients supports
the idea that subclinical vascular and neuronal dysfunction
develops.
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